Drudge Retort: The Other Side of the News
Saturday, September 14, 2019

At a time when health officials are calling for mass demonstrations in favor of new antibiotics, drug companies have stopped making them altogether. Their sole reason, according to a new report: profit.

Antibiotics are only used for a few days once in a while, and are being prescribed less as doctors become more aware of the dangers of over-prescription. Instead, drug companies are focusing on lucrative medications for chronic conditions like high cholesterol, arthritis, epilepsy, and cancer.

More

Comments

Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.

New and effective antibiotics are harder to come by due to their overuse. It's just a matter of time (now?) that some superbug will come along that is resistant to everything.

Maybe the reasoning is to stop giving bugs a reason to evolve into harder to treat strains.

#1 | Posted by goatman at 2019-09-15 12:33 AM | Reply

@#1 ... New and effective antibiotics are harder to come by due to their overuse. ...

The article mentions that the overuse aspect is declining.

Are the drug corporations really avoiding research on needed drugs just to please their shareholders?

#2 | Posted by LampLighter at 2019-09-15 01:24 AM | Reply

It's just a matter of time (now?) that some superbug will come along that is resistant to everything.

They can only evolve resistance to things they experience.

Maybe the reasoning is to stop giving bugs a reason to evolve into harder to treat strains.

Nope. New antibiotics are in development at the basic stage.

The better tactic would be to develop new antibiotics and only use them in last ditch situations.

#3 | Posted by jpw at 2019-09-15 01:31 AM | Reply | Newsworthy 1

Are the drug corporations really avoiding research on needed drugs just to please their shareholders?

This is an example of the market driven aspects screwing non-market driven aspects.

But it's now a basic science challenge. Pharma corps aren't going to spend the cash necessary to develop new antibiotics, at least not until academic science does the major leg work.

#4 | Posted by jpw at 2019-09-15 01:36 AM | Reply | Newsworthy 2

'MURICA!

#5 | Posted by Nixon at 2019-09-16 07:03 AM | Reply

All is not lost: "While several pharma giants have backed out of antibiotic research, Merck, Roche, GlaxoSmithKline and Pfizer all have active antibiotic research programs."

www.beckershospitalreview.com

#6 | Posted by MSgt at 2019-09-16 03:35 PM | Reply

Comments are closed for this entry.

Home | Breaking News | Comments | User Blogs | Stats | Back Page | RSS Feed | RSS Spec | DMCA Compliance | Privacy | Copyright 2019 World Readable

Drudge Retort